StonvexLoading…
StonvexStonvexStonvexCore line items from GOSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $16.95M | $48.47M | $34.67M | $21.38M |
Operating Income | $-44.87M | $-170.73M | $-124.69M | $-75.58M |
Net Income | $-46.66M | $-170.37M | $-123.13M | $-38.27M |
EPS (Diluted) | $-0.20 | $-0.75 | $-0.54 | $-0.33 |
Total Assets | $128.90M | $172.25M | $208.82M | $240.93M |
Total Liabilities | $290.38M | $295.01M | $291.15M | $287.03M |
Cash & Equivalents | $41.03M | $37.73M | $8.93M | $26.31M |
Free Cash Flow OCF − CapEx | $-38.72M | $-171.34M | $-123.03M | $-86.86M |
Shares Outstanding | 234.70M | 233.68M | 231.31M | 227.32M |